Moderate to severe plaque psoriasis

Active Ingredient: Dimethyl fumarate

Indication for Dimethyl fumarate

Population group: only adults (18 years old or older)

Dimethyl fumarate is indicated for the treatment of moderate to severe plaque psoriasis in adults in need of systemic medicinal therapy.

For this indication, competent medicine agencies globally authorize below treatments:

30-720 mg in 1-3 divided doses

Route of admnistration

Oral

Defined daily dose

30 - 720 mg

Dosage regimen

From 10 To 240 mg 3 time(s) per day every day

Loading dose

30 mg

Detailed description

To improve tolerability, it is recommended to begin treatment with a low initial dose with subsequent gradual increases. In the first week, dimethyl fumarate 30 mg is taken once daily (1 tablet in the evening). In the second week, dimethyl fumarate 30 mg is taken twice daily (1 tablet in the morning and 1 in the evening). In the third week, dimethyl fumarate 30 mg is taken three times daily (1 tablet in the morning, 1 at midday, and 1 in the evening). From the fourth week, treatment is switched to only 1 tablet of dimethyl fumarate 120 mg in the evening. This dose is then increased by 1 dimethyl fumarate 120 mg tablet per week at different times of day for the subsequent 5 weeks, as shown in the table below. The maximum daily dose allowed is 720 mg (3 × 2 tablets of dimethyl fumarate 120 mg).

WeekNumber of tabletsTotal daily dose (mg) of dimethyl fumarate
Morning Midday Evening
Dimethyl fumarate 30 mg
1 0 0 1 30
2 1 0 1 60
3 1 1 1 90
Dimethyl fumarate 120 mg
4 0 0 1 120
5 1 0 1 240
6 1 1 1 360
7 1 1 2 480
8 2 1 2 600
9+ 2 2 2 720

If a particular dose increase is not tolerated, it may be temporarily reduced to the last tolerated dose.

If treatment success is observed before the maximum dose is reached, no further increase of dose is necessary. After clinically relevant improvement of the skin lesions has been achieved, consideration should be given to gradual reduction of the daily dose of dimethyl fumarate to the maintenance dose required by the individual.

Dosage modifications may also be necessary if abnormalities in laboratory parameters are observed.

Dosage considerations

It must be swallowed whole with fluid during or immediately after a meal.

Active ingredient

Dimethyl fumarate

The anti-inflammatory and immunomodulating effects of dimethyl fumarate and its metabolite monomethyl fumarate are not fully elucidated but are thought to be mainly due to the interaction with the intracellular reduced glutathione of cells directly involved in the pathogenesis of psoriasis. Their main activity is considered to be immunomodulatory, resulting in a shift in T helper cells (Th) from the Th1 and Th17 profile to a Th2 phenotype.

Read more about Dimethyl fumarate

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.